Answers are grounded in this paper and cite their sources.
Optimization of postoperative recovery in older adult patients is a clinical priority. This study investigated the effects of intraoperative lidocaine combined with dexmedetomidine or remimazolam on postoperative rehabilitation in elderly patients undergoing lumbar spine surgery. In this randomized controlled trial, 270 older adult patients were randomly assigned to six groups based on the intraoperative intravenous anesthetic used: lidocaine (Group L), dexmedetomidine (Group D), remimazolam (Group R), lidocaine plus dexmedetomidine (Group LD), lidocaine plus remimazolam (LR), and and normal saline (Group C). The primary outcome was the global quality of recovery-40 (QoR-40) score at postoperative day 1 (POD 1). Secondary outcomes included gastrointestinal recovery, inflammatory cytokine levels (IL-6, TNF-α), and long-term quality of life (SF-12) at POD 180. The modified intention-to-treat population included 265 patients. Group LD achieved significantly higher global QoR-40 scores than Group C at both POD 1 and POD 3 (all P < 0.001). The mean difference between Group LD and Group C was 17.23 (95% CI: 11.88 to 22.58) at POD 1. For global QoR-40 scores at POD 1, factorial analysis revealed additive effects between lidocaine and dexmedetomidine on global QoR-40 scores at POD 1 ( P interaction = 0.408), but a significant sub-additive effect between lidocaine and remimazolam ( P interaction = 0.006). Group LD exhibited the fastest gastrointestinal recovery, with a significantly shorter time to first flatus compared to Group C (15 h vs. 22 h, P < 0.05). This was accompanied by significantly lower concentrations of pro-inflammatory cytokines (IL-6 and TNF-α) in Group LD on POD 1 (all P < 0.05). While Groups D and LD showed longer awakening times. Long-term quality of life (SF-12) at POD 180 did not differ significantly across groups ( P > 0.05). The combination of lidocaine and dexmedetomidine significantly improves early recovery in elderly patients through an additive interaction. This combination outperforms lidocaine and remimazolam, which exhibited sub-additive effects. Although no long-term benefits were observed, the lidocaine-dexmedetomidine regimen is a safe, mechanism-based approach for optimizing early functional restoration after major spine surgery. Trial registration number: ChiCTR2200062226, 30/07/2022. Title: “Effects of lidocaine in combination with dexmedetomidine or remimazolam on postoperative recovery and pulmonary function in elderly patients undergoing posterior lumbar spine surgery. Available online: https://www.chictr.org.cn .
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: